How does DEF stack up against Consumer Staples ETFs?

About a month ago, this blog profiled the defensive qualities of the three largest ETFs representing the US Consumer Staples Sector.  One of our readers asked a logical question.  How did DEF, the Invesco Defensive Equity ETF, stack up against the sector ETFs?  After all, its objective of its rules-based methodology is to select companies … Read more

Mid-Year Market Forecasts

The ETF reports on ValuEngine for funds that follow market benchmarks provide a side benefit in writing market analyses.  They allow me to discuss the implicit forecast for 1-, 3-, 6- and 12-month forecasts our models are making for each benchmark’s ETF portfolio.  This is because the ratings and projections combine bottom-up constituent analysis with … Read more

Drill, Baby, Drill? Oil ETFs

For each blog article, I scan through relevant groups of ETFs that relate to possible investment strategies.  Three ETFs from iShares by BlackRock stood out to me this week: IEO, IEZ, IYE.  All have ValuEngine’s strongest rating of 5 checks and all have fared very well in price performance during the past 6 months since … Read more

Defensive Sector ETFs for Turbulent Times

This week’s featured US equity ETFs, all focused on the US Consumer Staples Sector, are projected to outperform the market going forward. The similarities with last week’s blog end there.  These all get a more modest 4 (buy) recommendation.  Risk versus safety differentiate the last blog from this one. My last blog entry profiled ETF … Read more

Medical Miracles: Inside Biotech ETFs

The events of the past twelve months focused a lot of attention on amazing and life-altering developments made possible by the global biotech industry.  Although the major names we heard were Pfizer, AstraZeneca, Johnson & Johnson and Moderna, only the last was where the original research and patents that produced the CoVid-19 vaccines were developed.  … Read more

Inside Value ETFs

The market has been in a value phase the past 6 months which has been well documented by others.  The regime change was heartily welcomed by almost all managers of value funds, both active and passive. This is because the previous 13 years have been relentlessly difficult for value managers in terms of relative performance … Read more

Should Gold Have a Role in Your Portfolio?

By Herb Blank Our short answer is yes.  Generally speaking, the amount should be between 5% and 10% for diversification purposes. Gold doesn’t provide as much diversification as other assets in most time periods.  But in the greatest equity market collapses in history when the endurance of the US market and dollar as the safe … Read more

03/08/2021 What’s in Your Core?

By Herb Blank If you are an investor with less than $1 billion to invest and a holding horizon of more than 3 months, do NOT buy SPY to access exposure to the S&P 500.  This is true even though SPY has the most assets under management and the highest average trading volume by far. The simple … Read more

02/19/2021 ValuEngine Market Update, stock pick

ValuEngine is asked many times every day what our outlook for the market is for the next few months.  We always answer with uncertainty, as that is the nature of the markets these days. We are “generally positive” about the markets and recovery once we put Covid in the rear view mirror. But we are … Read more

Inside Actively Managed Equity ETFs

By Herbert Blank Actively managed ETFs have evolved very differently from index-driven ETFs.  Most of the assets have been accumulated in actively managed fixed income ETFs while the vast preponderance of Assets Under Management in Equity ETFs are index driven. Although there are many legacy reasons for this, the fact is that the efficiencies of … Read more